Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophren
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.62 -0.23 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.85 | 52 Week High | $66.55 | |||
| Open | $40.18 | 52 Week Low | $37.82 | |||
| Day High | $41.09 | P/E | N/A | |||
| Day Low | $39.50 | EPS | $0.00 | |||
| Volume | 4,596,572 | |||||
